Peel Hunt reiterated their hold rating on shares of Vectura Group (LON:VEC) in a report published on Wednesday, ThisIsMoney.Co.Uk reports.

A number of other analysts also recently weighed in on VEC. Morgan Stanley set a $28.00 price target on shares of BJs Wholesale Club and gave the company a hold rating in a research report on Friday, May 24th. JPMorgan Chase & Co. upgraded shares of Intelsat from a neutral rating to an overweight rating and set a $27.00 price target on the stock in a research report on Wednesday, April 3rd. Shore Capital downgraded shares of Smith & Nephew to a sell rating in a research report on Monday, June 10th. Finally, Numis Securities reiterated a buy rating and issued a GBX 115 ($1.50) price target on shares of Alliance Pharma in a research report on Friday, May 24th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of Buy and a consensus price target of GBX 130.33 ($1.70).

Shares of LON:VEC opened at GBX 80.15 ($1.05) on Wednesday. The firm has a market cap of $534.04 million and a P/E ratio of -6.07. The company has a 50 day moving average price of GBX 82.24. The company has a quick ratio of 1.90, a current ratio of 2.35 and a debt-to-equity ratio of 0.81. Vectura Group has a fifty-two week low of GBX 65.85 ($0.86) and a fifty-two week high of GBX 90.15 ($1.18).

Vectura Group Company Profile

Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta and Anoro Ellipta for the treatment of COPD.

Featured Story: What Are Treasury Bonds?

Analyst Recommendations for Vectura Group (LON:VEC)

Receive News & Ratings for Vectura Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group and related companies with MarketBeat.com's FREE daily email newsletter.